|
KYNB Kyntra Bio Inc 921299 |
| Balance Sheet |
|
Current Assets
|
$101,355,000.00 |
|
Assets
|
$109,629,000.00 |
|
Current Liabilities
|
$28,114,000.00 |
|
Liabilities
|
$118,919,000.00 |
|
Equity
|
$-43,803,000.00 |
|
Shares Out
|
4048000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,887,000.00 |
|
Investing Cash Flow
|
$3,018,000.00 |
| Market Analysis |
Market Cap
|
$27,485,920.00 |
|
Price
|
$6.75 |
|
PB
|
25.00 |
|
EPS
|
-3.76 |
|
PE
|
0.18 |
|
PS
|
2.07 |
|
FCF
|
$-13,887,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-3.61 |
|
|
2026-05-11 |
-3.74 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KYNB documents filed with the SEC.
KYNB Filings
Clear
